Skip to content
10-Q

Quarterly Report

MERIDIAN BIOSCIENCE, INC.

0001193125-22-143065

← back to feed
Filed
May 6, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Apr 30, 2022 43.58M sh
Shares Diluted Q2 2022 · Mar 31, 2022 44.26M sh
Shares Diluted Q2 2022 · Mar 31, 2022 44.11M sh
Shares Diluted Q2 2022 · Mar 31, 2021 44.12M sh
Shares Diluted Q2 2022 · Mar 31, 2021 43.96M sh
Capex Q2 2022 · Mar 31, 2022 $3.18M
Capex Q2 2022 · Mar 31, 2021 $11.96M
Operating Cash Flow Q2 2022 · Mar 31, 2022 $65.97M
Operating Cash Flow Q2 2022 · Mar 31, 2021 $41.49M
Long Term Debt Q2 2022 · Mar 31, 2022 $25M
Long Term Debt Q2 2022 · Sep 30, 2021 $60M
Cash And Equivalents Q2 2022 · Mar 31, 2022 $76.49M
Cash And Equivalents Q2 2022 · Sep 30, 2021 $49.77M
Cash And Equivalents Q2 2022 · Mar 31, 2021 $63.37M
Cash And Equivalents Q2 2022 · Sep 30, 2020 $53.51M
Stockholders Equity Q2 2022 · Mar 31, 2022 $374.63M
Stockholders Equity Q2 2022 · Dec 31, 2021 $345.22M
Stockholders Equity Q2 2022 · Sep 30, 2021 $328.3M
Stockholders Equity Q2 2022 · Mar 31, 2021 $309.47M
Stockholders Equity Q2 2022 · Dec 31, 2020 $278.87M
Stockholders Equity Q2 2022 · Sep 30, 2020 $247.63M
Current Liabilities Q2 2022 · Mar 31, 2022 $56.47M
Current Liabilities Q2 2022 · Sep 30, 2021 $47.16M
Current Assets Q2 2022 · Mar 31, 2022 $217.56M
Current Assets Q2 2022 · Sep 30, 2021 $192.81M
Total Assets Q2 2022 · Mar 31, 2022 $471.81M
Total Assets Q2 2022 · Sep 30, 2021 $449.72M
Eps Diluted Q2 2022 · Mar 31, 2022 $0.65
Eps Diluted Q2 2022 · Mar 31, 2022 $1.00
Eps Diluted Q2 2022 · Mar 31, 2021 $0.60
Eps Diluted Q2 2022 · Mar 31, 2021 $1.21
Eps Basic Q2 2022 · Mar 31, 2022 $0.66
Eps Basic Q2 2022 · Mar 31, 2022 $1.01
Eps Basic Q2 2022 · Mar 31, 2021 $0.61
Eps Basic Q2 2022 · Mar 31, 2021 $1.23
Sga Expense Q2 2022 · Mar 31, 2022 $18.56M
Sga Expense Q2 2022 · Mar 31, 2022 $33.22M
Sga Expense Q2 2022 · Mar 31, 2021 $12.93M
Sga Expense Q2 2022 · Mar 31, 2021 $24.86M
Rd Expense Q2 2022 · Mar 31, 2022 $5.69M
Rd Expense Q2 2022 · Mar 31, 2022 $11.89M
Rd Expense Q2 2022 · Mar 31, 2021 $6.07M
Rd Expense Q2 2022 · Mar 31, 2021 $11.72M
Net Income Q2 2022 · Mar 31, 2022 $28.75M
Net Income Q2 2022 · Mar 31, 2022 $44.09M
Net Income Q2 2022 · Mar 31, 2021 $26.3M
Net Income Q2 2022 · Mar 31, 2021 $53.08M
Operating Income Q2 2022 · Mar 31, 2022 $36.14M
Operating Income Q2 2022 · Mar 31, 2022 $56.42M
Operating Income Q2 2022 · Mar 31, 2021 $34.2M
Operating Income Q2 2022 · Mar 31, 2021 $68.87M
Gross Profit Q2 2022 · Mar 31, 2022 $68.48M
Gross Profit Q2 2022 · Mar 31, 2022 $117.64M
Gross Profit Q2 2022 · Mar 31, 2021 $57.77M
Gross Profit Q2 2022 · Mar 31, 2021 $119.32M
Cost Of Revenue Q2 2022 · Mar 31, 2022 $42.75M
Cost Of Revenue Q2 2022 · Mar 31, 2022 $81.94M
Cost Of Revenue Q2 2022 · Mar 31, 2021 $27.49M
Cost Of Revenue Q2 2022 · Mar 31, 2021 $58.86M
Revenue Q2 2022 · Mar 31, 2022 $111.23M
Revenue Q2 2022 · Mar 31, 2022 $199.57M
Revenue Q2 2022 · Mar 31, 2021 $85.26M
Revenue Q2 2022 · Mar 31, 2021 $178.18M